Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry

Royo Gracia S, Gaus K, Sewald N (2009)
FUTURE MEDICINAL CHEMISTRY 1(7): 1289-1310.

Download
No fulltext has been uploaded. References only!
Journal Article | Review | Published | English

No fulltext has been uploaded

Author
; ;
Abstract / Notes
Although not complying with Lipinski's rule, peptides are to an increasing extent being developed into new active pharmaceutical ingredients. This is mainly due to novel application routes, formulations and chemical modifications, which confer on the peptides improved uptake and increased metabolic stability. A brief survey of currently approved peptide drugs and the present scope of the application of peptides as drugs is provided. Cyclic peptides are emerging as an interesting class of peptides with conformational rigidity and homogeneity, high receptor affinity and selectivity, increased metabolic stability and - in special cases - even oral availability. Challenges and new methodology for the synthesis of cyclic peptides are outlined and an overview of approaches toward the design of peptide conformation and peptide modification by nonproteinogenic building blocks is given.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Royo Gracia S, Gaus K, Sewald N. Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry. FUTURE MEDICINAL CHEMISTRY. 2009;1(7):1289-1310.
Royo Gracia, S., Gaus, K., & Sewald, N. (2009). Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry. FUTURE MEDICINAL CHEMISTRY, 1(7), 1289-1310. doi:10.4155/FMC.09.97
Royo Gracia, S., Gaus, K., and Sewald, N. (2009). Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry. FUTURE MEDICINAL CHEMISTRY 1, 1289-1310.
Royo Gracia, S., Gaus, K., & Sewald, N., 2009. Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry. FUTURE MEDICINAL CHEMISTRY, 1(7), p 1289-1310.
S. Royo Gracia, K. Gaus, and N. Sewald, “Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry”, FUTURE MEDICINAL CHEMISTRY, vol. 1, 2009, pp. 1289-1310.
Royo Gracia, S., Gaus, K., Sewald, N.: Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry. FUTURE MEDICINAL CHEMISTRY. 1, 1289-1310 (2009).
Royo Gracia, Soledad, Gaus, Katharina, and Sewald, Norbert. “Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry”. FUTURE MEDICINAL CHEMISTRY 1.7 (2009): 1289-1310.
This data publication is cited in the following publications:
This publication cites the following data publications:

15 Citations in Europe PMC

Data provided by Europe PubMed Central.

Stapled Peptides by Late-Stage C(sp3 )-H Activation.
Noisier AF, García J, Ionuţ IA, Albericio F., Angew Chem Int Ed Engl 56(1), 2017
PMID: 27900857
Syntheses and preliminary evaluation of [(18) F]AlF-NOTA-G-TMTP1 for PET imaging of high aggressive hepatocellular carcinoma.
Li Y, Zhang D, Shi Y, Guo Z, Wu X, Ren JL, Zhang X, Wu H., Contrast Media Mol Imaging 11(4), 2016
PMID: 26931574
Proline cis-trans isomerization and its implications for the dimerization of analogues of cyclopeptide stylostatin 1: a combined computational and experimental study.
López-Martínez C, Flores-Morales P, Cruz M, González T, Feliz M, Diez A, Campanera JM., Phys Chem Chem Phys 18(18), 2016
PMID: 27097793
Cyclopeptides containing the DEKS motif as conformationally restricted collagen telopeptide analogues: synthesis and conformational analysis.
Wodtke R, Ruiz-Gómez G, Kuchar M, Pisabarro MT, Novotná P, Urbanová M, Steinbach J, Pietzsch J, Löser R., Org Biomol Chem 13(6), 2015
PMID: 25503999
Enantiomeric cyclic peptides with different Caco-2 permeability suggest carrier-mediated transport.
Marelli UK, Bezençon J, Puig E, Ernst B, Kessler H., Chemistry 21(22), 2015
PMID: 25917866
New peptide architectures through C-H activation stapling between tryptophan-phenylalanine/tyrosine residues.
Mendive-Tapia L, Preciado S, García J, Ramón R, Kielland N, Albericio F, Lavilla R., Nat Commun 6(), 2015
PMID: 25994485
cis-Peptide Bonds: A Key for Intestinal Permeability of Peptides? .
Marelli UK, Ovadia O, Frank AO, Chatterjee J, Gilon C, Hoffman A, Kessler H., Chemistry 21(43), 2015
PMID: 26337831
Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally Absorbed.
Hill TA, Lohman RJ, Hoang HN, Nielsen DS, Scully CC, Kok WM, Liu L, Lucke AJ, Stoermer MJ, Schroeder CI, Chaousis S, Colless B, Bernhardt PV, Edmonds DJ, Griffith DA, Rotter CJ, Ruggeri RB, Price DA, Liras S, Craik DJ, Fairlie DP., ACS Med Chem Lett 5(10), 2014
PMID: 25313329
Synthesis of constrained head-to-tail cyclic tetrapeptides by an imine-induced ring-closing/contraction strategy.
Wong CT, Lam HY, Song T, Chen G, Li X., Angew Chem Int Ed Engl 52(39), 2013
PMID: 23934633
Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1.
Conradi J, Huber S, Gaus K, Mertink F, Royo Gracia S, Strijowski U, Backert S, Sewald N., Amino Acids 43(1), 2012
PMID: 21915696
Synthesis of allene triazole through iron catalyzed regioselective addition to propargyl alcohols.
Yan W, Ye X, Weise K, Petersen JL, Shi X., Chem Commun (Camb) 48(29), 2012
PMID: 22382692

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 21426104
PubMed | Europe PMC

Search this title in

Google Scholar